💉 Could buffer design revolutionize how we detect circulating tumor cells (CTCs) in cancer patients?

🔗 Design of buffer property for the new enrichment method of circulating tumor cell based on immunomagnetic-negative separation. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2024.11.033

📚 CSBJ Nanoscience & Advanced Materials: https://csbj.org/nano

#CancerResearch #LiquidBiopsy #Oncology #Immunotherapy #PrecisionMedicine #CancerDiagnostics #Biomarkers #CancerDetection

We’re proud to spotlight Reccan AB, a Sweden-based biotechnology company and a core partner in the SHIELD project. Reccan is pioneering the development of diagnostic tools for early cancer detection, with a strong focus on pancreatic ductal adenocarcinoma (PDAC), one of Europe’s deadliest cancers.

Reccan’s work is central to SHIELD’s mission to redefine cancer screening and prevention in Europe.

#SHIELDProject #EarlyDetection #CancerDiagnostics #PancreaticCancer #HealthInnovation

🌌 Could we see cancer differently—without staining, just by its optical fingerprint?

🔗 Phasor-FLIM and SHG imaging for quantitative analysis of lung cancer autofluorescence. DOI: https://doi.org/10.1016/j.csbj.2025.08.010

📚 CSBJ Quantum Biology and Biophotonics: https://www.csbj.org/qbio

#CancerResearch #LungCancer #Biophotonics #Autofluorescence #Histopathology #PrecisionDiagnostics #BiomedicalOptics #MedicalImaging #QuantitativePathology #ComputationalBiology #CancerDiagnostics #HealthTech @csbj

Congratulations to Aiina Robotics on winning first place at this year’s #TUMIDEAward! The teams from ReduCO2 and Bioexotec won 2nd and 3rd place, respectively: http://go.tum.de/240156 🎉

#ConstructionTech #CO2Reduction #CancerDiagnostics
#startups

📷A. Heddergott

RT @DXCover@twitter.com

🩸Liquid biopsies: the future of cancer early detection

Read our recent review describing how a spectroscopic approach may pave the way for more efficient cancer diagnostics.

https://rdcu.be/c6CcI

#CancerDiagnostics #LiquidBiopsy #Cancer